Science
2020 Was a Breakout Year for Crispr – WIRED
Between glimpses of a medical cure and winning science’s shiniest prize, this proved to the gene-editing technology’s biggest year yet.
The pandemic sped up the need for such tests. This summer, the FDA authorized two Crispr-based tests, both for detecting SARS-CoV-2. Boston-based Sherlock Biosciences received the green light for its test in May, and the Bay Areas Mammoth Biosciences followed in August. It marked the first time the FDA has allowed a Crispr-based diagnostic tool to be used on patients. The tests still need to be analyzed in a lab, but they are faster than the standard method for detecting SARS-CoV-2, called PCR,…
-
Noosa News22 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General24 hours agoLabor to squeeze public service, sparking warnings of job losses
-
Noosa News24 hours agoQLS submits key budget requests – Proctor